[6-K] Cellebrite DI Ltd. Warrants Current Report (Foreign Issuer)

Rhea-AI Filing Summary

The Form 6-K furnished on 8 July 2025 by Cellebrite DI Ltd. (symbol: CLBTW) discloses a leadership transition in the finance function. According to the attached press release (Exhibit 99.1), David Barter has been appointed Chief Financial Officer and current CFO Dana Gerner will retire. The filing states that the first paragraph of the press release is incorporated by reference into the company’s existing Form S-8 (File Nos. 333-260878, 333-278130) and Form F-3 (File No. 333-259826) registration statements.
No additional financial metrics, strategic commentary, or effective-date details are included. Apart from the exhibit index and routine signature block, there are no other material disclosures.

Positive

• Orderly disclosure: The company furnished a Form 6-K and incorporated the press release into existing registration statements, demonstrating regulatory compliance.
• Named successor: Appointment of David Barter as CFO indicates succession planning rather than leaving the position vacant.

Negative

• CFO retirement: Departure of Dana Gerner may introduce short-term uncertainty until the new CFO is fully established.
• Lack of detail: The filing omits effective dates, handover timeline, and background on the incoming CFO, limiting investor visibility.

Insights

Financial Analyst

TL;DR – CFO transition announced; neutral near-term impact, watch execution.

The filing simply furnishes the press release naming David Barter as the new CFO and noting the retirement of Dana Gerner. While a CFO change is always noteworthy, the absence of timing, succession details, or financial commentary limits immediate valuation effect. Investors should monitor forthcoming quarters for any strategic or reporting shifts under Barter, but today’s disclosure does not alter earnings outlook or balance-sheet assumptions.

Corporate Governance Expert

TL;DR – Routine leadership transition; governance procedures appear followed.

Cellebrite has used a Form 6-K to promptly inform the market and update its registration statements, indicating compliance discipline. The attachment of the full press release as an exhibit aligns with best practices for transparency. However, the filing provides no insight into search process, overlap period, or board rationale, limiting shareholders’ ability to assess succession planning robustness.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

 

For the month of July 2025

 

Commission File Number 001-40772

 

 

 

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

 

 

 

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

 

 

 

EXPLANATORY NOTE

 

On July 8, 2025, Cellebrite DI Ltd. (the “Registrant” or “Cellebrite”) issued a press release (the “Press Release”) titled “Cellebrite Names David Barter Chief Financial Officer. CFO Dana Gerner to Retire”. A copy of the press release is attached to this Report on Form 6-K as Exhibit 99.1.

 

The first paragraph of the Press Release is incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022, to be a part thereof from the date on which this Report on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

EXHIBIT INDEX

 

Exhibit	 	Description
99.1	 	Press release titled “Cellebrite Names David Barter Chief Financial Officer. CFO Dana Gerner to Retire”.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 	Cellebrite DI Ltd.
 	 
Date: July 8, 2025	By:	/s/ Ayala Berler Shapira
 	 	Ayala Berler Shapira, Adv.
 	 	General Counsel

 

3

 

FAQ

What did Cellebrite (CLBTW) announce in its July 8 2025 Form 6-K?

The filing reports that David Barter has been appointed Chief Financial Officer and current CFO Dana Gerner will retire.

Is there any financial data or guidance change in this Form 6-K?

No. The document only furnishes the CFO transition press release and contains no earnings or guidance updates.

How is the press release related to Cellebrite’s registration statements?

The first paragraph of the release is incorporated by reference into the company’s Form S-8 (File Nos. 333-260878, 333-278130) and Form F-3 (File No. 333-259826).

Does the filing specify when David Barter will assume the CFO role?

No effective date or transition timeline is provided in the text of the 6-K.

Are there any other material developments disclosed in this 6-K?

No. Beyond the CFO transition, the document contains only the exhibit index and signature block.